Professor Matthew Kiernan leads the ForeFront Motor Neurone Disease (MND) Program. The team’s work is focussed on clinical neurology, in particular disease pathophysiology and treatment strategies of neurological disorders.

The team are currently investigating the mechanisms and possible prevention of neurodegeneration in MND, chemotherapy-induced neurotoxicity, stroke, Machado-Joseph disease, spinal muscular atrophy and other inherited neuropathies.

The team also conducts clinical trials investigating potential drug treatments for MND, multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.

As the Bushell Professor of Neurology, Professor Matthew Kiernan is dually located at the BMRI and the Royal Prince Alfred Hospital. Professor Kiernan provides academic leadership in neurology at the BMRI as well as across the University, and promotes partnerships between researchers and healthcare practitioners to optimise the translation of research into improved healthcare practice and policy.